Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920123 · ClinicalTrials.gov registry record · NA
Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic
A NA study, sponsored by University of Massachusetts, Amherst.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04920123 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 19 participants.
The verdict
NCT04920123, a NA study, has completed, sponsored by University of Massachusetts, Amherst.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.
Interventions
- DEVICE Neuro-World
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-02-17 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04920123
The ClinicalTrials.gov registry entry for NCT04920123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Amherst, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neuro-World is the first listed.
NCT04920123 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04920123 about?
NCT04920123 is a clinical study titled "Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic". This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.
What is the current status of trial NCT04920123?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2022-02-17. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04920123?
The interventions under investigation include: Neuro-World (DEVICE).
Who is sponsoring clinical trial NCT04920123?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.